Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma
Open Access
- 24 January 2012
- journal article
- Published by Springer Science and Business Media LLC in Clinical Sarcoma Research
- Vol. 2 (1), 2
- https://doi.org/10.1186/2045-3329-2-2
Abstract
Myxoid liposarcoma (MLS) is a soft tissue sarcoma with adipocytic differentiation characterized by a unique chromosome rearrangement, t(12;16)(q13;p11). The exact efficacy of chemotherapy in MLS has not been clearly established. We retrospectively analyzed the records of 37 histologically confirmed MLS patients who were treated at the University of Texas MD Anderson Cancer Center from January 2000 to December 2009 with doxorubicin 75-90 mg/m2 over 72 hours combined with ifosfamide 10 gm/m2 in the first-line setting. Response was assessed using RECIST and Choi criteria. The Kaplan-Meier method and log-rank test was used to estimate clinical outcomes. The median follow-up period was 50.1 months. The overall response rates were 43.2% using RECIST and 86.5% using the Choi criteria. The 5-year disease-free survival rate was 90% for patients with resectable tumors. Median time to progression and overall survival time for the advanced-disease group were 23 and 31.1 months, respectively. Our study demonstrates that doxorubicin-ifosfamide combination therapy has a role in the treatment of MLS. The Choi criteria may be more sensitive in evaluating response to chemotherapy in MLS.Keywords
This publication has 19 references indexed in Scilit:
- Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcomaAnnals of Oncology, 2011
- Detection of myxoid liposarcoma-associated FUS–DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assayLaboratory Investigation, 2010
- Resection of Uninvolved Adjacent Organs Can Be Part of Surgery for Retroperitoneal Soft Tissue SarcomaJournal of Clinical Oncology, 2009
- Efficacy of Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft Tissue Sarcoma: An Open-Label Randomized Phase II Study of the Spanish Group for Research on SarcomasJournal of Clinical Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Metastatic myxoid liposarcomas: imaging and histopathologic findingsSkeletal Radiology, 2008
- Excellent Local Control Rates and Distinctive Patterns of Failure in Myxoid Liposarcoma Treated With Conservation Surgery and RadiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response CriteriaJournal of Clinical Oncology, 2007
- Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location.American Journal of Roentgenology, 1995
- Liposarcoma A study of 55 cases with a reassessment of its classificationThe American Journal of Surgical Pathology, 1979